SavedAdd your journal

Journals / Marmara Medical Journal / 2019 / Cilt: 32 - Sayı: 1

Evaluating adherence to long-term prophylaxis treatment with danazol in adult hereditary angioedema patients: A real life study

Erişkin herediter anjiödem hastalarında danazol ile yapılan uzun dönem profilaksi tedavisine uyumun değerlendirilmesi: Gerçek bir yaşam çalışması

Semra TİRYAKİ DEMİR
Derya ÜNAL
Müge OLGAÇ
Aslı GELİNCİK
Raif COŞKUN
Bahauddin ÇOLAKOĞLU
Suna BÜYÜKÖZTÜRK
Pages
7–13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: To investigate the adherence to the prophylactic

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the adherence to the prophylactic
📊
Key Findings & Data:Objective: To investigate the adherence to the prophylactic
💡
Conclusion & Impact:Objective: To investigate the adherence to the prophylactic
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tedaviye uyum · Herediter anjioödem · Tedavi

Abstract

Objective: To investigate the adherence to the prophylactic

Özet

Amaç: Herediter anjioödem (HAÖ) hastalarında profilaktik

🔖

Cite This Article

DEMİR, S. T., ÜNAL, D., OLGAÇ, M., GELİNCİK, A., COŞKUN, R., ÇOLAKOĞLU, B., BÜYÜKÖZTÜRK, S. (2019). Evaluating adherence to long-term prophylaxis treatment with danazol in adult hereditary angioedema patients: A real life study. Marmara Medical Journal, Cilt: 32 - Sayı: 1, 7–13. https://ajindex.com/articles/283791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis and approach to treatment for angioedema: consesnsus report from the Hereditary Angioedema International Working Group. Allergy 2014
  2. doi: 10.1111/all.12380 2. Zuraw BL. Hereditary angioedema. N Engl J Med 2008
  3. doi: 10.1056/NEJMcp0803977. 3. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005
  4. Zilberberg M, Jacobsen T, Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc 2010
  5. doi: 10.2500/ aap.2010.31.3403. 5. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, Lopez- Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevelance in Spain. Ann Allergy Asthma Immunol 2005
  6. Bygum A. Hereditary angioedema in Denmark: a nationwide survey. Br J Dermatol 2009
  7. doi: 10.1111/j.1365- 2133.2009.09366.x. 7. Craig T, Aygören-Pürsün E, Bork K, et al. WAO Guideline for the management of hereditary angioedema. World Allergy Organ J 2012
  8. doi: 10.1097/ WOX.0b013e318279affa. 8. Caballero T, Baeza ML, Cabanas R, et al. Consensus statement on the diagnosis, management and the treatment of angioedema mediated by bradikynin. Part II. Treatment, follow up, and special situations. J Investig Allergol Clin Immunol 2011
  9. Costantino G, Casazza G, Bossi I, Duca P, Cicardi M. Longterm prophylaxis in hereditary angio-edema: a systematic review. BMJ Open 2012
  10. e000524. doi: 10.1136/ bmjopen-2011-000524. 10. Wilson DA, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE. Economic costs associated with acute attacks and long term management of hereditary angioedema. Ann Allergy Asthma Immunol 2010
  11. doi: 10.1016/j. anai.2010.01.024. 11. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedem: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 2010
  12. doi:10.2500/aap.2010.31.3394. 12. Nordenfelt P, Dawson S, Wahlgren CF, Lindfors A, Malbris L, Björkander J. Quantifying the burden of disease health state in patients with hereditary angiopedema in Sweeden. Allergy Asthma Proc 2014
  13. doi: 10.2500/ aap.2014.35.3738. 13. Cabellero T, Aygören-Pürsün E, Bygum A, et al. The humanistic burden of hered